Miragen Therapeutics' Eva van Rooij
May 08, 2012
Miragen Therapeutics' Eva van Rooij discusses microRNA-based therapeutics, the challenges associated with chronic microRNA knockdown, therapeutic microRNA antagonists, and more.
Other Genomeweb Videos



























